Pascal Biosciences Inc., a drug discovery and development company, researches and develops biotechnology products for the treatment of cancer and for the enhancement of immune system in Canada. Its research programs include the development of Anti-VpreB, a therapeutic monoclonal antibody for treatment of B-cell precursor acute lymphoblastic leukemia in collaboration with the University of New Mexico; optimization of novel classes of molecules that restore immune recognition and killing of cancer cells; and regulating activity of immune system calcium channels to combat cancers, infections, and autoimmune diseases. The company has a collaboration agreement with the University of British Columbia. Pascal Biosciences Inc. is headquartered in Vancouver, Canada.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-604-6886775
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees4
Next Earnings DateN/A
OptionableNot Optionable
Pascal Biosciences (CVE:PAS) Frequently Asked Questions
What is Pascal Biosciences' stock symbol?
Pascal Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "PAS."
Has Pascal Biosciences been receiving favorable news coverage?
Media stories about PAS stock have been trending somewhat negative recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pascal Biosciences earned a daily sentiment score of -1.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Pascal Biosciences.
Who are some of Pascal Biosciences' key competitors?
Some companies that are related to Pascal Biosciences include Altimmune (ALT), Ixico (IXI), Acrux (ACR), Kazia Therapeutics (KZA), Scancell (SCLP), Memphasys (MEM), Prana Biotechnology (PBT), Ceapro (CZO), Galena Biopharma (SLS), Protalix Biotherapeutics (PLX), Proteomics Int Lab (PIQ), Midatech Pharma (MTPH), Skinbiotherapeutics (SBTX), Biocardia (BCDA) and Immuron (IMC).
What other stocks do shareholders of Pascal Biosciences own?
Who are Pascal Biosciences' key executives?
Pascal Biosciences' management team includes the folowing people:
- Dr. Patrick W. Gray, CEO & Director (Age 67)
- Ms. Judith F. Dalling L.L.B., CFO & Corp. Sec. (Age 64)
- Mr. Carl Weissman, Acting Pres (Age 57)
How do I buy shares of Pascal Biosciences?
Shares of PAS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Pascal Biosciences' stock price today?
One share of PAS stock can currently be purchased for approximately C$0.13.
How big of a company is Pascal Biosciences?
What is Pascal Biosciences' official website?
How can I contact Pascal Biosciences?
Pascal Biosciences' mailing address is 400 Burrard St Suite 1780, VANCOUVER, BC V6C 3A6, Canada. The company can be reached via phone at +1-604-6886775.
MarketBeat Community Rating for Pascal Biosciences (CVE PAS)
MarketBeat's community ratings are surveys of what our community members think about Pascal Biosciences and other stocks. Vote "Outperform" if you believe PAS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PAS will underperform the S&P 500 over the long term. You may vote once every thirty days.
